Latest on Ultrasound Renal Denervation

  • Published:  22 June 2022
  • Likes: 

    Heart Icon

    1

Up Next
  • episode_image
    1h 4m 58s
    Part 7 | Session 1 ACC 2022 Symposium
    Michael Weber, Felix Mahfoud, Ajay J Kirtane, Michael Bloch
  • episode_image
    59m 32s
    Part 7 | Session 2 TCT 2021 Symposium
    Chandan Devireddy, Ajay J Kirtane, Felix Mahfoud, Naomi Fisher

Latest on Ultrasound Renal Denervation

  • Published:  22 June 2022
  • Likes: 

    Heart Icon

    1

Average (ratings)
No ratings
Your rating
Overview

Ultrasound Renal Denervation (uRDN) is an innovative therapy option for the treatment of uncontrolled hypertension. uRDN therapy is delivered in a minimally invasive procedure that may lower high blood pressure by treating overactive renal nerves with ultrasound energy.

 

This page provides an overview of uRDN technology and the latest evidence from its associated RADIANCE clinical program.

 

The PARADISETM System is Limited to Investigational Use Only in the United States. Approved for distribution in CE mark countries only.
This educational content is supported by:

What you will learn:

  • How uRDN works and its potential benefits for patients suffering from uncontrolled hypertension
  • The clinical evidence supporting uRDN and its implications for the field of hypertension
  • The process for building a uRDN centre and therapy network

This page is designed for:

  • Interventional cardiologists
  • General cardiologists
  • Hypertension specialists
  • Nephrologists
  • Interventional radiologists

More from this programme

Part 4

RADIANCE II Pivotal Trial for Paradise Ultrasound Renal Denervation System in Patients With Hypertension

Part 6

Patient Perspective & Provider Referral Development

Part 7

Discussion With Experts

Faculty Biographies

Roland E Schmieder

Roland E Schmieder

Professor of Internal Medicine, Nephrology and Hypertension, Head of the Clinical Research Centre and Vice Chair of the Department of Nephrology and Hypertension

Roland E Schmieder is a German physician-scientist whose career has been dedicated to internal medicine, nephrology, and hypertension. He has spent the majority of his professional life in Germany, where he has combined patient care, clinical research, and academic leadership at major university and community hospitals. His work has focused on the prevention and treatment of cardiovascular and renal disease, with an emphasis on hypertension and vascular risk.

 

Academic History

Professor Schmieder graduated in medicine from the University of Tübingen, Germany. He completed his post-graduate medical training in nephrology, cardiology, and hypertension at the University Hospital of Bonn. He later pursued advanced training at the Alton Ochsner Foundation in New Orleans, United States, where he further expanded his expertise in cardiovascular and renal medicine and clinical research.

 

Career Overview

Professor Schmieder is Professor of…

View full profile